![]() AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural | ![]() Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. | ![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ||
Founding Date | Founding Date 2010 | Founding Date 1997 | Founding Date 2007 | Founding Date 2006 |
Type | Type Subsidiary | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Norcross, US HQ | Locations Roseville, US HQ | Locations Cambridge, US HQ | Locations Cambridge, GB HQ Wien, AT Cambridge, US |
Employees | Employees 6 | Employees 542% increase | Employees 324187% increase | Employees 39 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $236.2m (FY, 2025) | Revenue (est.) £18.7m (FY, 2018) |
Net income | Net income N/A | Net income N/A | Net income ($5.3m) (FY, 2025) | Net income (£2.6m) (FY, 2018) |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 1.6m (over 11 years ago) | Latest funding round N/A | Latest funding round $ 9.4m (over 12 years ago) |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 5.1m | Total funding raised N/A | Total funding raised $ 57.3m |

Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
View company
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company